IMMUNOBIOTIC COMPLEX Russian patent published in 2019 - IPC C12N1/20 A61K35/745 A61K35/747 A61K31/702 

FIELD: medicine.

SUBSTANCE: invention refers to an immunobiotic complex for normalizing intestinal microflora of an organism. Said complex includes dry microbial mass of living bacteria and biologically active substances (BAS). One dose of the complex contains two formulations, one of which contains lactobacteria LGG (lactic acid bacteria Lactobacillus rhamnosus) in amount of 3 × 10⁹ up to 4 × 10⁹ CFU per one dose, and the other contains BAS, specifically lysozyme in amount of 50 to 300 mg per single dose; fructooligosaccharides (WCF), namely: inulin or raftilose or raftilin in amount of 800–1000 mg per one dose; as well as choline and iodine or eicosapentoenoic acid and docosahexaenoic acid in amount of choline 50 to 100 mg, iodine 50 to 100 mcg, eicosapentoenoic acid 138 to 460 mg, docosahexaenoic acid 90 to 380 mg.

EFFECT: invention provides wider spectrum of its complex action, enhanced synergetic interaction between all active components.

1 cl, 5 ex